ArticleBMC medicine2026
Perceptions of HPV vaccination: a qualitative study with adolescents, parents, school staff, and pharmacists.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Latent profiles of HPV vaccine-related health beliefs and their associations with vaccination intention among college students: a global health perspective.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite its proven efficacy in preventing HPV-related cancers, HPV vaccine uptake remains suboptimal in France (i.e., coverage reached 54.6% for girls and 15.8% for boys in 2023). Understanding stakeholder perspectives across key dimensions related to vaccination perceptions, HPV-related representations, barriers, facilitators, and communication dynamics is essential. This study investigates the knowledge, attitudes, barriers, and facilitators related to HPV vaccination among four stakeholder groups: adolescents, parents, school staff, and pharmacists.
methodsA total of 63 semi-structured interviews were conducted with middle school students (n = 15), parents (n = 18), school staff (n = 15), and pharmacists (n = 15) in France. Thematic analysis was used to identify common and group-specific representations, emotional responses, and social dynamics influencing HPV vaccine acceptance.
resultsParticipants generally supported HPV vaccination as a cancer-prevention tool but highlighted barriers such as limited HPV knowledge, gender-based misconceptions, unease discussing sexuality, concerns about side effects, and logistical hurdles. Facilitators included trust in healthcare professionals, pharmacies' accessibility, and the school's potential as an information platform. While adolescents expressed injection anxiety and a need for age-appropriate, anonymous formats, parents emphasized clear, data-driven communication. Overall, teachers felt underprepared, and pharmacists showed willingness to engage but required better informational tools. All groups called for targeted, emotionally resonant, multi-channel communication.
conclusionsIncreasing HPV vaccination requires coordinated efforts that support schools, mobilize trusted healthcare professionals, and deliver clear, stigma-free information. Practical tools and targeted training could further strengthen stakeholder engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.